Related Experiment Video
Updated: Aug 5, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Do We Preserve Tumor Control Probability (TCP) in FLASH Radiotherapy? A Model-Based Analysis.
Hans Liew1,2,3, Stewart Mein1,2,3,4, Thomas Tessonnier5
1Clinical Cooperation Unit Translational Radiation Oncology, German Cancer Consortium (DKTK) Core-Center Heidelberg, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
FLASH radiotherapy shows potential for normal tissue sparing but may reduce tumor control. Model analysis suggests tumor sparing effects might be too small to detect, potentially impacting clinical efficacy.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Background:
- FLASH radiotherapy utilizes ultra-high dose-rates (uHDR) for potential normal tissue sparing.
- Iso-effectiveness in tumors is often inferred from growth kinetics, but clinical relevance requires further investigation.
Purpose of the Study:
- To investigate the clinical treatment outcome implications of tumor iso-effectiveness indications in FLASH radiotherapy.
- To assess the tumor control probability (TCP) of FLASH radiotherapy under various treatment parameters.
Main Methods:
- A model-based analysis combining the UNIVERSE model for uHDR sparing with tumor volume kinetics and TCP models.
- Comparison of model predictions with experimental data.
- Investigation of TCP by varying dose-rate, fractionation, and oxygen concentration.
Main Results:
- The developed framework accurately describes reported tumor growth kinetics.
- Sparing effects in tumors might be present but too small to be detected in current experimental setups.
- TCP predictions indicate a potential substantial loss of treatment efficacy in FLASH radiotherapy.
Conclusions:
- The clinical viability of FLASH radiotherapy requires careful consideration of potential TCP loss.
- Fractionation scheme, oxygen levels, and DNA repair kinetics are critical variables influencing FLASH radiotherapy efficacy.

